Centre for DNA Fingerprinting & Diagnostics

What Centre for DNA Fingerprinting & Diagnostics does

The Centre for DNA Fingerprinting and Diagnostics (CDFD) is an autonomous research institute funded by India's Department of Biotechnology, Ministry of Science and Technology, and operating as a constituent of the Biotechnology Research and Innovation Council (BRIC). Headquartered in Hyderabad, Telangana, CDFD delivers DNA fingerprinting and molecular diagnostic services, and runs the National Genomics Core facility (also marketed as CDFD Genomics Core) which provides whole genome sequencing, transcriptome sequencing, metagenomics, epigenomics, forensic genomics, enrichment-based sequencing, customized genomics solutions, and bioinformatics services on Illumina (Miseq FGx, Nextseq 2000) and Oxford Nanopore (GridION X5) platforms alongside Agilent QC instrumentation. Its research portfolio spans seven defined themes — including cell cycle and signaling, epigenetics and chromatin dynamics, genomic analysis and informatics, immunological response and infectious disease, microbial pathogenesis, molecular and genetic basis of disease, and neurobiology and developmental processes — supported by a PhD program, post-doctoral and project positions, summer training, and a biotechnology startup incubation program. The institute's customer base is horizontal across academic and research institutions, healthcare and medical institutions, government agencies and law enforcement (forensic DNA work), and biotechnology and pharmaceutical companies, with services accessed via a quote-based request system. Revenue is derived primarily from government appropriations and collaborative project grants, with commercial genomics services as an incremental stream; pricing is available only on request and is not publicly disclosed.

Name

Centre for DNA Fingerprinting & Diagnostics

Legal name

Centre for DNA Fingerprinting and Diagnostics

Website

https://cdfd.org.in

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

The Centre for DNA Fingerprinting and Diagnostics (CDFD) is a Government of India autonomous research institute under the Department of Biotechnology and BRIC, headquartered in Hyderabad, delivering DNA fingerprinting, molecular diagnostics, and high-end genomics services across academic, healthcare, government, and biotech clients.

Ownership category

akta.pro rank

Product category

Genomics and Molecular Diagnostics Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Genomic sequencing services
• DNA fingerprinting services
• Molecular diagnostics
• Forensic genomics
• Bioinformatics analysis

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Distribution channels1 record

Marketing channels6 records

Core offering

CDFD is a government-funded autonomous research institute that provides high-throughput genomic sequencing, DNA fingerprinting, and molecular diagnostic services through its National Genomics Core (CDFD Genomics Core) and diagnostic facilities. Its core offerings include Whole Genome Sequencing, Transcriptome Sequencing, Metagenomics, Epigenomics, Forensic Genomics, Enrichment-based Sequencing, Bioinformatics Services, DNA Fingerprinting (human and plant), and molecular Diagnostics for academic, healthcare, government, and industry clients. The institute also conducts original research across cell biology, epigenetics, immunology, microbial pathogenesis, neurobiology, and disease genetics.

Product overview

CDFD operates as a genomics and molecular diagnostics research institute rather than a product company. The organization provides a portfolio of genomic services including Whole Genome Sequencing, Transcriptome Sequencing, Metagenomics, Epigenomics, Forensic Genomics, and Enrichment-based Sequencing through its CDFD Genomics Core facility. Additional services include DNA Fingerprinting (human and plant), Diagnostics, Experimental Animal Facility, and Sophisticated Equipment Facility access. The institute also offers academic programs (PhD) and startup incubation services for the biotechnology ecosystem.

Differentiator

Problem solved

Functional benefit

Products and services

• Whole Genome Sequencing

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Mapmygenome: Indian personal genomics and molecular diagnostics provider offering preventive, reproductive and clinical genomic tests. Competes for diagnostic genomic testing demand that CDFD also serves.
• MedGenome: India-headquartered commercial genetic diagnostics and genomics services company offering NGS panels, reproductive and oncology testing. Competes with CDFD for the same hospital and research customers on turnaround and test menu.
• Strand Life Sciences: Indian genomics and bioinformatics company providing clinical genomic testing, sequencing services and analytics to hospitals and research institutions. Directly comparable service portfolio and target market to CDFD's Genomics Core.
• National Centre for Biological Sciences (NCBS): Tata Institute-affiliated Indian life sciences research centre with deep genomics and bioinformatics capabilities. Comparable as a publicly funded Indian research institute conducting fundamental and translational genomics.
• National Institute of Biomedical Genomics (NIBMG): Autonomous Indian government institute under DBT focused on biomedical genomics, population genomics and cancer genomics. Highly comparable mission, funding structure and customer base to CDFD.
• Institute of Genomics and Integrative Biology (IGIB): CSIR-run Indian government genomics and molecular medicine research institute. Closely comparable to CDFD as a publicly funded Indian genomics research lab offering sequencing, diagnostics, and translational research under a national mandate.
• Institute of Life Sciences (ILS): DBT autonomous research institute in Bhubaneswar working on infectious disease, cancer and translational biology with shared genomic infrastructure. Comparable in mandate, governance and DBT oversight.

Broad incumbents

• Broad Institute: Large US genomics and biomedical research organization offering high-throughput sequencing and clinical genomics. Comparable as a flagship public-interest genomics platform, but with substantially larger scale, partnerships and IP base.
• Wellcome Sanger Institute: World-leading genomic sequencing and bioinformatics centre. Analogous to CDFD in mission (large-scale genomics, infectious disease surveillance, training) but at a materially larger scale and global footprint.

Others

• Council of Scientific and Industrial Research (CSIR): Parent body of IGIB and other life-science labs analogous to CDFD's BRIC/DBT parent structure. Relevant as the institutional ecosystem peer governing similarly mandated genomic research institutes in India.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/dbt_cdfd
• YouTubeyoutube.com/channel/UCPFOXwtNTL2sozAsB3Z3VZw
• Facebookfacebook.com/cdfd.org.in
• LinkedInlinkedin.com/company/national-genomics-core-cdfd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centre for DNA Fingerprinting & Diagnostics